Your patients will be asking about a new prescription motion sickness med they saw advertised. Here’s what to tell them.

In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Vickie Danaher, PharmD, discusses preventing motion sickness with today’s OTC and prescription products. She covers where the new neurokinin-1 antagonist tradipitant fits into therapy, which options are first-line, non-drug measures patients can try, and more.

This is an excerpt from our July 2026 Pharmacy Essential Updates continuing education webinar series.

🏷️ Use code cc1026 at checkout for 10% off a new or upgraded subscription.

******

CE Information:

None of the speakers have anything to disclose.

TRC Healthcare offers CE credit for this podcast for pharmacist subscribers at our platinum level or higher and pharmacy technician subscribers. Log in to your Pharmacist’s Letter or Pharmacy Technician’s Letter account and look for the title of this podcast in the list of available CE courses.

Claim Credit

******

The clinical resources related to this podcast are part of a subscription to Pharmacist’s Letter, Pharmacy Technician’s Letter, and Prescriber Insights:

• Article: Explain How New Rx Tradipitant Stacks Up for Motion Sickness
• CE Course: Pharmacist’s Guide to Travel Medicine
• CE Course: Managing Common Travel-Related Illnesses

Don’t miss out! Subscribe today to stay ahead with trusted insights and tools. 

🎓 Are you a student? Great news—students can access a free version of Pharmacist’s Letter.

🗪 Send us Fan Mail

Email us: ContactUs@trchealthcare.com. 

The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. 

Find the show on YouTube by searching for ‘TRC Healthcare’ or clicking here.

Learn more about our product offerings at trchealthcare.com.